Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Norse Atlantic ASA – Mandatory notification of trade – Receipt of Subscription Rights

Arendal, 8 June 2026: Reference is made to the stock exchange announcement published by Norse Atlantic ASA (the "Company") on 5 June 2026 regarding the commencement of the subscription period in the rights issue (the "Rights Issue"). As part of this process, subscription rights have been allocated to primary insiders (PDMRs) of the Company and their close associates based on their existing shareholdings in the Company as of the Record Date, 4 June 2026. Please see the attached mandatory notification forms for further details of the primary insiders' and their close associates' receipt

Composition of Konecranes Plc’s Shareholders’ Nomination Board

KONECRANES PLC STOCK EXCHANGE RELEASE June 8, 2026 at 7:15 PM EEST   Composition of Konecranes Plc’s Shareholders’ Nomination Board   Konecranes has a Shareholders' Nomination Board which prepares proposals to the Annual General Meeting, and, if necessary, to an Extraordinary General Meeting, for the election and remuneration of the members of the Board of Directors and to identify potential Board member candidates.   The Shareholders' Nomination Board is comprised of one member appointed by each of the four largest shareholders of Konecranes Plc. The shareholders entitled

Repurchase of shares in Synsam during June 1, 2026 – June 5, 2026 (week 23)

Synsam AB (publ) (LEI code: 5493000TMEGW9DHNOQ70) ("Synsam" or the "Company") has during June 1, 2026, to June 5, 2026, repurchased in total 125,000 own shares (ISIN code: SE0016829709) as part of the share buy-back program initiated by the board of directors of Synsam in order to adjust the Company's capital structure.The repurchases form part of the share buy-back program of maximum MSEK 200 announced by Synsam on May 28, 2026, and which runs during the period from June 1, 2026, until February 26, 2027. The share buy-back program is being carried out in accordance with the EU Market Abuse

Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer

Press Release – Oslo, Norway, June 8, 2026: Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The collaboration encompasses Photocure’s blue light cystoscopy (BLC[®]) registry in bladder cancer and the ArteraAI Bladder Test, an AI-powered digital pathology test currently in development for patients with bladder cancer.As healthcare systems increasingly embrace precision medicine, the demand for advanced precision diagnostics in uro-oncology continues to grow. Photocure, already recognized

Share buybacks in Skandinaviska Enskilda Banken AB (publ) during the period 01 June 2026 - 05 June 2026

During the period 01 June 2026 - 05 June 2026, Skandinaviska Enskilda Banken AB (publ) (LEI code F3JS33DEI6XQ4ZBPTN86) repurchased own Class A shares (ISIN: SE0000148884) for capital management purposes as follows: +-------+-----------------+-------------------+-----------------+|Date  |Aggregated Daily |Weighted average |Total daily || |Volume (number of|Share price per day|transaction value|| |shares)  |(SEK)  |(SEK)  |+-------+-----------------+-------------------+-----------------+|01/06/2|249,050  |182.4256

Embla Medical hf: Transactions in relation to Share Buyback Program

Announcement no. 30/2026 8 June 2026 Reykjavik, Iceland/Copenhagen, Denmark, 8 June 2026. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced transactions in relation to its share buyback program (“Program”), see also Company Announcement no. 61/2025 dated 23 December 2025. During the period 1 June to 4 June 2026 Embla Medical has acquired 58,784 shares under the Program at the average price of DKK 26.98. Following the transactions below, the Company holds 1,743,095 shares, corresponding to 0.41% of the Company’s

#26-205 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Helsinki Marks an International Contribution to Wellbeing with a Summer of Aalto Design and Architecture

Aalto Design – Shapes of Wellbeing exhibition at Architecture & Design Museum Helsinki. Photo: Paavo Lehtonen, Architecture & Design Museum. ·The international influence of Aino, Elissa and Alvar Aalto in progressing the concept of wellbeing within Modernist design and architecture will be explored in a new exhibition at Architecture & Design Museum Helsinki. ·The exhibition is timely, as Aalto’s architecture has been proposed for inclusion on the UNESCO World Heritage List. The Aalto Works nomination comprises 13 buildings across Finland, that have influenced the

1 World Cup Game or 8 months of Slot Spins: New Study Reveals a Single World Cup Ticket Equals Over 5,000 Slot Spins

A new data study by CasinoTopsOnline reveals that the price of a single ticket to the final could literally fund months of continuous gameplay, shedding light on just how financially out of reach the tournament has become for the everyday fan.The 2026 FIFA World Cup is shaping up to be the most expensive tournament in football history. With ticket prices on official resale platforms reaching jaw-dropping heights, a new study has put the eye-watering costs into perspective by comparing them to something unexpected: online slot spins. According to data compiled 

Fredrik Tumegård appointed CEO of Stim

The Board of Directors of Stim has appointed Fredrik Tumegård as CEO of the organisation. Since November 2025, he has led the organisation as interim CEO and now has the Board's continued confidence to lead Stim into the next phase of development.AI, digitalisation, globalisation and evolving consumption patterns are rapidly reshaping the way music is created, used and valued. At the same time, the need for strong collective organisations that can safeguard the rights of music creators and ensure fair remuneration is growing in an increasingly complex market. Fredrik Tumegård brings

Inify Laboratories signs agreement with University Hospitals Plymouth NHS Trust to support faster prostate cancer diagnostics

South Oxfordshire, UK, 8th June 2026 – Inify Laboratories, a unique laboratory service that provides diagnostics within pathology, today announced that it has entered into an agreement with University Hospitals Plymouth NHS Trust (UHP) to launch a service evaluation. The evaluation aims to support the consistent delivery of a 7-day histopathology turnaround time and improve performance improvement against the 28-day Faster Diagnosis Standard (FDS). The partnership seeks to ensure patients with suspected prostate cancer receive timely, high-quality diagnostic results.   Across the

Monthly Factsheet

FIDELITY SPECIAL VALUES PLC   LEI: 549300XODK7D2K2KYV43   Monthly Factsheet as at 30 April 2026   The latest Monthly Factsheet is available on the Company’s website at: https://investment-trusts.fidelity.co.uk/fidelity-special-values   Copies of the Monthly Factsheet have also been submitted to the UK Listing Authority and will shortly be available for inspection on the National Storage Mechanism (NSM). Please note that documents submitted to the NSM will usually be available for inspection within two business days of this notice being given.   08 June 2026

Monthly Factsheet

FIDELITY EUROPEAN TRUST PLC   LEI: 549300UC0QPP7Y0W8056   Monthly Factsheet as at 30 April 2026   The latest Monthly Factsheet is available on the Company’s website at: https://investment-trusts.fidelity.co.uk/fidelity-european-trust   Copies of the Monthly Factsheet have also been submitted to the UK Listing Authority and will shortly be available for inspection on the National Storage Mechanism (NSM). Please note that documents submitted to the NSM will usually be available for inspection within two business days of this notice being given.   08 June 2026

Monthly Factsheet

FIDELITY EMERGING MARKETS LIMITED (the ‘Company’) Legal Entity Identifier (LEI): 213800HWWQPUJ4K1GS84   Monthly Factsheet as at 30 April 2026   The latest Monthly Factsheet is available on the Company’s website at: https://investment-trusts.fidelity.co.uk/fidelity-emerging-markets-limited   Copies of the Monthly Factsheet have also been submitted to the UK Listing Authority and will shortly be available for inspection on the National Storage Mechanism (NSM). Please note that documents submitted to the NSM will usually be available for inspection within two business days

There are no items matching the current filter
There are no more items matching the current filter
Back to top